Annual Current Liabilities
$13.30 M
+$6.79 M+104.16%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual total current liabilities is currently $13.30 million, with the most recent change of +$6.79 million (+104.16%) on 31 December 2023. During the last 3 years, it has risen by +$12.69 million (+2070.15%). ACRV annual current liabilities is now at all-time high.ACRV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$14.82 M
+$3.54 M+31.33%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly total current liabilities is currently $14.82 million, with the most recent change of +$3.54 million (+31.33%) on 30 September 2024. Over the past year, it has increased by +$5.52 million (+59.36%). ACRV quarterly current liabilities is now at all-time high.ACRV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +104.2% | +59.4% |
| 3 y3 years | +2070.2% | +408.5% |
| 5 y5 years | - | - |
ACRV Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2070.2% | at high | +408.5% |
| 5 y | 5 years | at high | +2070.2% | at high | +408.5% |
| alltime | all time | at high | +2070.2% | at high | +408.5% |
Acrivon Therapeutics Common Stock Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.82 M(+31.3%) |
| June 2024 | - | $11.28 M(+24.8%) |
| Mar 2024 | - | $9.04 M(-32.0%) |
| Dec 2023 | $13.30 M | $13.30 M(+43.1%) |
| Sept 2023 | - | $9.30 M(+32.5%) |
| June 2023 | - | $7.02 M(+23.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $5.68 M(-12.8%) |
| Dec 2022 | $6.52 M(+123.6%) | $6.52 M(+2.0%) |
| Sept 2022 | - | $6.39 M(+43.6%) |
| June 2022 | - | $4.45 M(+52.8%) |
| Dec 2021 | $2.91 M(+375.4%) | - |
| Dec 2021 | - | $2.91 M |
| Dec 2020 | $613.00 K | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual total current liabilities?
- What is the all time high annual current liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual current liabilities year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly current liabilities year-on-year change?
What is Acrivon Therapeutics Common Stock annual total current liabilities?
The current annual current liabilities of ACRV is $13.30 M
What is the all time high annual current liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual total current liabilities is $13.30 M
What is Acrivon Therapeutics Common Stock annual current liabilities year-on-year change?
Over the past year, ACRV annual total current liabilities has changed by +$6.79 M (+104.16%)
What is Acrivon Therapeutics Common Stock quarterly total current liabilities?
The current quarterly current liabilities of ACRV is $14.82 M
What is the all time high quarterly current liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly total current liabilities is $14.82 M
What is Acrivon Therapeutics Common Stock quarterly current liabilities year-on-year change?
Over the past year, ACRV quarterly total current liabilities has changed by +$5.52 M (+59.36%)